Literature DB >> 24323166

The effects of dexamethasone and levobupivacaine on postoperative pain in modified radiofrequency assisted uvulopalatoplasty (MRAUP) surgery.

Arzu Onder Tatar1, Ozgur Yoruk, Metin Akgun.   

Abstract

The objective of this prospective, randomized study was to evaluate the effect of pre-emptive local infiltration of lidocaine, lidocaine plus dexamethasone, levobupivacaine and levobupivacaine plus dexamethasone on postoperative pain in Modified Radiofrequency Assisted Uvulopalatoplasty (MRAUP) cases. Sixty adult patients (44 males and 16 females) aged 32-51 years with simple snoring were divided into four groups. The anesthesia of the patients in the first group was achieved with lidocaine HCl, in the second group, with lidocaine HCl and dexamethasone sodium phosphate, in the third group, with levobupivacaine, and in the fourth group, levobupivacaine and dexamethasone sodium phosphate. All the patients were applied Modified Radiofrequency Assisted Uvulopalatoplasty technique. The pain experienced by the patients during swallowing and at rest on the 1st, 3rd, 5th, 7th, and 10th day and analgesic consumption were evaluated using standard 10 cm visual analog scales. The mean duration of operation in the group that received lidocaine HCl was 22 ± 3 min, while in the group that received levobupivacaine HCl was 27 ± 4 min. There were statistically significant differences between the groups for analgesic effects on the 1st, 3rd, 5th, and 7th day and for the amount of analgesics used, on the 1st, 3rd, and 5th day. The best results were obtained in the group that received levobupivacaine HCl and steroid (p < 0.001). Steroid and local anesthetic combinations are superior to controls in the management of postoperative pain in MRAUP surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323166     DOI: 10.1007/s00405-013-2859-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  Laser CO2 for snoring. Preliminary results.

Authors:  Y V Kamami
Journal:  Acta Otorhinolaryngol Belg       Date:  1990

2.  Pre-emptive analgesia.

Authors:  H J McQuay
Journal:  Br J Anaesth       Date:  1992-07       Impact factor: 9.166

3.  Snoring and sleep architecture.

Authors:  V Hoffstein; J H Mateika; S Mateika
Journal:  Am Rev Respir Dis       Date:  1991-01

4.  Effects of peritonsillar infiltration on post-tonsillectomy pain. A double-blind study.

Authors:  M Goldsher; L Podoshin; M Fradis; S Malatskey; R Gerstel; S Vaida; L Gaitini
Journal:  Ann Otol Rhinol Laryngol       Date:  1996-11       Impact factor: 1.547

5.  Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers.

Authors:  K Knudsen; M Beckman Suurküla; S Blomberg; J Sjövall; N Edvardsson
Journal:  Br J Anaesth       Date:  1997-05       Impact factor: 9.166

6.  A prospective study comparing the analgesic efficacy of levobupivacaine, ropivacaine and bupivacaine in pediatric patients undergoing caudal blockade.

Authors:  Christian Breschan; Robert Jost; Ruth Krumpholz; Florian Schaumberger; Haro Stettner; Peter Marhofer; Rudolf Likar
Journal:  Paediatr Anaesth       Date:  2005-04       Impact factor: 2.556

7.  Effect of pre- vs postoperative tonsillar infiltration with local anesthetics on postoperative pain after tonsillectomy.

Authors:  S Molliex; P Haond; D Baylot; J M Prades; M Navez; Z Elkhoury; C Auboyer
Journal:  Acta Anaesthesiol Scand       Date:  1996-11       Impact factor: 2.105

8.  Evaluating the effects of oral prednisolone on recovery after tonsillectomy: a prospective, double-blind, randomized trial.

Authors:  C E Palme; P Tomasevic; D V Pohl
Journal:  Laryngoscope       Date:  2000-12       Impact factor: 3.325

Review 9.  Levobupivacaine.

Authors:  G A McLeod; D Burke
Journal:  Anaesthesia       Date:  2001-04       Impact factor: 6.955

10.  Mid-line swelling of the palate.

Authors:  Lakshmanan Suresh; Luis Edmundo Martinez Calixto; Alfredo Aguirre; Stuart L Fischman
Journal:  J Laryngol Otol       Date:  2004-05       Impact factor: 1.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.